An Innovative Platform for Objective Monitoring of Instrumental Activities of Daily Living

TerminatedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
DementiaCognitive ImpairmentAlzheimer Disease
Interventions
DIAGNOSTIC_TEST

IADLSys system

Subjects will receive IADLSys system which includes interactive tablet and 5 paired pTAGs (bluetooth sensors to attach to objects of interest at home). The pTAGs monitor activities of daily living to assess if they are being completed and communicate with the tablet to keep record of interactions. We anticipate IADLSys enables to distinguish between groups with and without cognitive impairment and determine the severity of cognitive impairment in the cognitive impaired group.

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioSensics

INDUSTRY

lead

Bijan Najafi, PhD

OTHER

NCT05703490 - An Innovative Platform for Objective Monitoring of Instrumental Activities of Daily Living | Biotech Hunter | Biotech Hunter